glp-1 drugs retatrutide Retatrutide, the next generation of drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Retatrutide: Unapproved Weight Loss Drug

Aimen Arij Jun 21, 2026 34 min Fat Loss & Metabolic Health Retatrutide and PCOS: What We Actually Know About Insulin Resistance The honest answer first

For related questions about unexpected symptoms on semaglutide, the guide on whether semaglutide lowers your immune system addresses a different concern that sometimes gets conflated with drug test questions in online discussions

All other uses: Take 1 capsule two or three times daily

Our board-certified physicians are here for you and your specific health concerns

They also assume that the effects from the trials which were on adults with obesity, type 2 diabetes, or established cardiovascular or kidney disease also apply to healthier adults